These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1452399)
41. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA). Etievant M; Leluc B; David B Agents Actions; 1988 Jun; 24(1-2):137-44. PubMed ID: 3261498 [TBL] [Abstract][Full Text] [Related]
42. Multiple effects of a diamidine (propamidine) on complement activation. Vogt W; Hinsch B; Schmidt G; Von Zabern I Immunology; 1979 Jan; 36(1):131-7. PubMed ID: 422224 [TBL] [Abstract][Full Text] [Related]
43. Complement modulatory activity of bisbenzylisoquinoline alkaloids isolated from Isopyrum thalictroides--I. Influence on classical pathway in human serum. Ivanovska N; Nikolova P; Hristova M; Philipov S; Istatkova R Int J Immunopharmacol; 1999 May; 21(5):325-36. PubMed ID: 10408629 [TBL] [Abstract][Full Text] [Related]
44. Potential therapeutic effects of boswellic acids/Boswellia serrata extract in the prevention and therapy of type 2 diabetes and Alzheimer's disease. Gomaa AA; Farghaly HA; Abdel-Wadood YA; Gomaa GA Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2167-2185. PubMed ID: 34542667 [TBL] [Abstract][Full Text] [Related]
45. SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb. Rajagopal V; Leksa N; Gorham R; Jindal S; Nair S; Knockenhauer K; Chan J; Byun T; Mercadante C; Moore S; Panicker S; Parry G; Storek M Blood Adv; 2023 Aug; 7(16):4258-4268. PubMed ID: 36897252 [TBL] [Abstract][Full Text] [Related]
46. The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase. Kerr MA; Parkes C Biochem J; 1984 Apr; 219(2):391-9. PubMed ID: 6611150 [TBL] [Abstract][Full Text] [Related]
47. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates. Bureeva S; Andia-Pravdivy J; Symon A; Bichucher A; Moskaleva V; Popenko V; Shpak A; Shvets V; Kozlov L; Kaplun A Bioorg Med Chem; 2007 May; 15(10):3489-98. PubMed ID: 17383882 [TBL] [Abstract][Full Text] [Related]
48. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase. Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379 [TBL] [Abstract][Full Text] [Related]
49. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway. Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629 [TBL] [Abstract][Full Text] [Related]
50. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5. Sandoval A; Ai R; Ostresh JM; Ogata RT J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385 [TBL] [Abstract][Full Text] [Related]
51. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5. Strunk RC; Giclas PC J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706 [No Abstract] [Full Text] [Related]
52. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Fearon DT Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688 [TBL] [Abstract][Full Text] [Related]
54. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. Krych-Goldberg M; Hauhart RE; Porzukowiak T; Atkinson JP J Immunol; 2005 Oct; 175(7):4528-35. PubMed ID: 16177096 [TBL] [Abstract][Full Text] [Related]
56. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a. Nicholson-Weller A; Burge J; Austen KF J Immunol; 1981 Nov; 127(5):2035-9. PubMed ID: 6913607 [TBL] [Abstract][Full Text] [Related]
57. Defined Structure-Activity Relationships of Boswellic Acids Determine Modulation of Ca2+ Mobilization and Aggregation of Human Platelets by Boswellia serrata Extracts. Siemoneit U; Tausch L; Poeckel D; Paul M; Northoff H; Koeberle A; Jauch J; Werz O Planta Med; 2017 Aug; 83(12-13):1020-1027. PubMed ID: 28403501 [TBL] [Abstract][Full Text] [Related]
58. Complement receptor is an inhibitor of the complement cascade. Iida K; Nussenzweig V J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481 [TBL] [Abstract][Full Text] [Related]
59. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor. Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408 [TBL] [Abstract][Full Text] [Related]